HOUSTON , Sept. 14, 2017 -- TPC Group announced today that it has resumed full operations at both its Houston and Port Neches facilities. Initial operations at the Houston facility started as early as September 2 and the majority of operations were on-line by September 7, 2017. Port Neches brought initial operations capability on-line on September 8 with production restored by September 13, 2017.
“The efforts of TPC’s employees helping each other, helping neighbors and the community, and restoring our operational capability has been remarkable,” said TPC Group Chairman, President and CEO, Ed Dineen. “I am truly humbled, proud and amazed at the overall response to this tragic and catastrophic storm.”
“We know that there are many suppliers and customers who count on TPC as an integral part of their businesses,” said Charlie Graham, senior vice president, commercial. “We are very pleased that we have recovered so quickly to be there for them.”
TPC Group’s Lake Charles Terminal was not been impacted by the storm and continues to maintain normal operations.
About TPC Group
TPC Group Inc. is a leading producer of value-added products derived from niche petrochemical raw materials, such as C4 hydrocarbons, and provider of critical infrastructure and logistics services along the Gulf Coast. TPC Group sells its products into a wide range of performance, specialty and intermediate segments, including synthetic rubber, fuels, lubricant additives, plastics and surfactants. Headquartered in Houston, Texas, with an operating history of more than 70 years, TPC Group has manufacturing facilities in the industrial corridor adjacent to the Houston Ship Channel and Port Neches, Texas, and operates a product terminal in Lake Charles, Louisiana. For more information, visit the TPC Group's website at www.tpcgrp.com.
CONTACT:
Andrew Grygiel, Investor Relations
713.840.2045
Sara Cronin, Media Relations
713.475.5243


Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
FDA Approves Mitapivat for Anemia in Thalassemia Patients
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance 



